Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison study of pegylated somatropin response variability in children with growth hormone deficiency
ChiCTR1800017144Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of genotropin miniquick in growth hormone deficiency (GHD) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Height standard deviation score. Started Apr 2018; status: recruiting.
02
Drugs
genotropin miniquick
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on ChiCTR1800017144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017144.